Gewandter Team News
Mentee Accomplishments
April 4th, 2024
March 15th, 2024
Soroush Besharat, MD (URMC Anesthesia resident), Madelaine Rangel, BS (URMC medical student) and Karim Saab, MD (URMC Anesthesia Postdoc fellow) will be presenting the posters listed below. Dr. Saab was also invited to give an oral presentation on his abstract at the USASP Clinical Trials Special Interest group meeting.
“Personalized Trial Outcomes for Painful Chemotherapy-Induced Peripheral Neuropathy (CIPN): A Strategy to Increase Assay Sensitivity”
“Mean of Daily vs. Single Week Recall-Based Pain Quality Assessments in Painful Chemotherapy-induced Peripheral Neuropathy (CIPN) Trials: Implications for Assay Sensitivity.”
Additional residents who contributed to this work include Fallon O. France and Meghan Park
Nishtar M, Mark R, Langford DJ, McDermott MP, Markman JD, Evans SR, France FO, Park M, Sharma S, Turk DC, Dworkin RH, Gewandter JS. Evaluating the balance of benefits and harms in chronic pain clinical trials: prioritizing individual participants over individual outcomes. RAPM, 2023, epub ahead of print.
Knoerl R, Sohn MB, Foust M, Francar L, O’Rourke MA, Morrow G, Mustian K, Gauthier L, Gewandter JS. Exploring Analgesic Use Patterns among Cancer Survivors with Chronic Chemotherapy-Induced Neurotoxicity. Oncology Nursing Forum.
Dr. Gewandter's Recent Accomplishments
May 20th, 2024
https://open.spotify.com/episode/0spLSbMYIzQ84PGLZmk2iH?si=X_P53aGdTSCKkknao65Mbw
March 4th, 2024
Jennifer Gewandter, Phd, MPH of the Department of Anesthesiology and Perioperative Medicine has been selected as 2024 Visiting Professor and Johns Hopkins Blaustein Pain Treatment Center Grand Rounds lecturer.
The title of her presentation will be “Chronic pain clinical trials: Balancing theory and practice.”
https://jhjhm.zoom.us/rec/share/o10_8fsKspEomjHps4u3h4_-_V3JR9QVQijiWHVLItZUG-a15l72dMKCplZcuDpL.lhfmpab7lGIT9RbI
Passcode:Ks!ST1q#
Dr. Gewandter has been selected to speak at the International Association for the Study of Pain (IASP) 2024 World Congress in Amsterdam.
She will be the chair of a 3-speaker session: “Personalized and Multidimensional Outcomes for Pain to Improve Clinical Meaning and Sensitivity.” Her talk will be entitled “Personalized outcomes for neuropathic pain trials: A participant-centered approach.”
February 29th, 2024
Dr. Gewandter has been invited to serve as faculty at the 2nd annual NIH-sponsored PURPOSE (Positively Uniting Researchers of Pain to Opine, Synthesize, & Engage) Network meeting aimed at helping to advance the careers of Junior researchers.
Dr. Gewandter will speak about her perspectives on publishing and editing in the pain field and will serve on a panel of K24 awardees discussing their experience with the grant mechanism
Dr. Gewandter is one of 11 mid-career pain researchers in the country to be accepted to the first annual United States Association for the Study of Pain Leadership Academy.